Antidepressant response and plasma concentrations of bupropion

J Clin Psychiatry. 1983 May;44(5 Pt 2):137-9.

Abstract

A double-blind multicenter evaluation compared the antidepressant efficacy of bupropion (Wellbutrin) to both placebo and amitriptyline (Elavil, Endep) in adult patients who met DSM-III criteria for major depressive disorder. Steady-state plasma samples were obtained 11-12 hours and 4 hours after the last dose in 50 and 44 patients, respectively, who were treated for 6 weeks with bupropion. There was a curvilinear relationship between antidepressant efficacy and trough plasma bupropion concentrations, with maximum response observed at 5-100 ng/ml and virtually none below 25 ng/ml. The increase in plasma bupropion concentration from the trough level to the 4 hour postdose peak level was also positively related to antidepressant response.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Amitriptyline / therapeutic use
  • Antidepressive Agents / blood*
  • Antidepressive Agents / therapeutic use
  • Bupropion
  • Clinical Trials as Topic
  • Depressive Disorder / blood
  • Depressive Disorder / drug therapy*
  • Depressive Disorder / psychology
  • Double-Blind Method
  • Hospitalization
  • Humans
  • Middle Aged
  • Placebos
  • Propiophenones / blood*
  • Propiophenones / therapeutic use
  • Psychiatric Status Rating Scales

Substances

  • Antidepressive Agents
  • Placebos
  • Propiophenones
  • Bupropion
  • Amitriptyline